Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2023 and 2024.
-
Tight liquidity NBB
Cash and receivables cover 51 % of short-term debt in 2024; threshold 65 %.
Financials
Financial year 2024
TRAK 1 ONCOLOGY VENTURES from Kapellen, company number BE0705826933, closed financial year 2024 with a result of € -22,537 after tax. For that financial year TRAK 1 ONCOLOGY VENTURES recorded a gross margin of € -20,720 and equity of € 9.8 million. Compared with financial year 2023, the result moved from € -12,284 to € -22,537. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2025.
€ 9.8 million
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -22,537
▼ 83 % more loss than in 2023
Profit after tax over the fiscal year.
€ 33,240
▼ 88% vs 2023
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 3 million.
People and assets in 2024
€ 344
▼ 66% vs 2023
Book value of vehicles, furniture and equipment.
Debts at end 2024
None
No bank loans on the last day of the fiscal year.
€ 5,185
▼ 38% vs 2023
Supplier invoices still open on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2021 | 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|---|
| Gross margin | € -6,782 | € -408 | € -10,210 | € -20,720 | ▼ € 10,510 |
| Profit after taxes | € 135,773 | € 812,689 | € -12,284 | € -22,537 | ▼ € 10,254 |
| Equity | € 7,777,054 | € 9,815,440 | € 9,803,156 | € 9,780,619 | |
| Total debts | € 2,468,525 | € 2,072,535 | € 2,679,733 | € 2,940,562 | ▲ 10% |
| Cash | € 238,649 | € 328,985 | € 279,456 | € 33,240 | ▼ 88% |
| Retained profit | € 2,238,604 | € 3,061,990 | € 3,049,706 | € 3,027,169 | ▼ 1% |
| Balance sheet total | € 10,245,579 | € 11,887,976 | € 12,482,889 | € 12,721,181 | ▲ 2% |
Key figures of TRAK 1 ONCOLOGY VENTURES, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to TRAK 1 ONCOLOGY VENTURES?
What happened at TRAK 1 ONCOLOGY VENTURES in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2024: loss of € 22,537. filed late Source: NBB ↗
- New establishment in Kapellen. KBO
- Ronald VAN CAMP became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 135,773 profit in 2021 to € 22,537 loss in 2024.
Paid € 98,437 in corporate taxes since 2021.
Best year ever: 2022, with € 812,689 profit.
A new publication or filing at TRAK 1 ONCOLOGY VENTURES? We notify you, reason included.
Follow TRAK 1 ONCOLOGY VENTURESDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind TRAK 1 ONCOLOGY VENTURES is Ronald VAN CAMP. It owns 30% of DATABUILD PROJECTS, 20% of INDUSTRIEBOUW CAN CAMP and 10% of DATABUILD ESTATES itself.
Directors
According to the 2024 annual accounts
Ronald VAN CAMP
Director
Also active at: INDUSTRIEBOUW VAN CAMP, DATABUILD RETAIL, DATABUILD ESTATES, Databuild Projects, DATABUILD EUROPE
since 2018
Establishments
Establishment units
Physical locations of this company
Torenlei 2
2950 Kapellen
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0705.826.933
- VAT number
- BE 0705.826.933
- Registered office
- Torenlei 2, 2950 Kapellen
- Names & denominations
- TRAK 1 ONCOLOGY VENTURES
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 26 September 2018
- Peppol
- Active · Active since 2 Dec 2025
- Activities · NACE
Overige zakelijke dienstverlening, neg
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering